Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J. 2009;30(3):314-20.Keller T, Messow CM, Lubos E et al (2009) Cystatin C and cardiovascular mortality in patients ...
Heart Failure (DELIVER) randomized clinical trial including 6263 patients, dapagliflozin reduced the risk of the composite of cardiovascular death and heart failure events similarly across the spectrum of baseline kidney function; dapagliflozin slowed the rate of kidney function decline, compared with ...
However, the clinical benefit associated with finerenone was maintained even in the setting of elevated potassium, and the risk of hypokalemia was reduced with finerenone. Appropriate dose selection according to baseline kidney function and dose adjustments in response to potassium levels...
Although the EF is a continuous measure with considerable variability, in this comprehensive Review we suggest that HFmrEF is a useful categorization of patients with HF and shares the most important clinical features with HFrEF, which supports the renaming of HFmrEF to HF with mildly reduced EF....
Finerenone in Patients With Heart Failure, Chronic Kidney Disease, and Type 2 DiabetesFurther Reading featured Edoxaban Antithrombotic Therapy for Patients With Atrial Fibrillation and Stable CAD N. Engl. J. Med · September 19, 2024 updated story of the week Aortic...
Association of kidney function with physical performance: the Maastricht study Ioannis Bellos Smaragdi Marinaki Vassiliki Benetou Journal of Nephrology(2024) Albuminuria as a biomarker of severity in diabetic retinopathy and in the response to intravitreal treatment in diabetic macular edema ...
In addition to the inability of vRB-1B to infect OU2 cells, all cell types in which propagation of virulent MDV is possible, such as CEC, chicken kidney cell (CKC), or duck embryo fibroblast (DEF) cultures, do not expresses significant levels of MHC class I on the cell surface (Jar...
Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney functionCHILD patientsLISINOPRILKIDNEY physiologyACE inhibitorsPHARMACOKINETICSGLOMERULAR filtration rateAims: Lisinopril, an angiotensin‐converting enzyme inhibitor, is a frequently presc...
(sustained decrease in eGFR ≥50% relative to baseline over at least 4 weeks, or sustained eGFR decline in eGFR to <15 mL/min/1.73 m2, or initiation of dialysis or kidney transplant); and time to all-cause death (tested outside the α control hierarchy for the other se...
[PP.22.17] THE LEFT VENTRICLE DIASTOLIC FUNCTION PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION AND MILDLY REDUCED KIDNEY FUNCTIONNew methods of evaluationdoi:10.1097/01.hjh.0000492071.04931.c0Torbas, O.Sirenko, Y.Radchenko, G.Rekovets, O.